Novartis acquires DTx Pharma in potential $1B deal

By BioSpace
| July 18, 2023

DTx Pharma focuses on developing therapies targeting disorders affecting the nervous system, which aligns with Novartis’ efforts to expand its neuroscience pipeline.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...